Category: Blog

Retatrutide FDA Approval Status LegitScript Talk to a Board-Certified Doctor Free consultation. 15,000+ patients. From $99/month ✓ Free visit ✓ Free shipping ✓ Free supplies Start Free Consultation → Affirm. Klarna. Afterpay. HSA/FSA Understanding Retatrutide’s Current Approval So, what’s the deal with retatrutide and the FDA right now? Basically, it’s still in the testing phase. Think of it like a really promising student who hasn’t graduated yet. The studies are showing some pretty impressive results, especially when it comes to weight loss and managing blood sugar, even better than some of the drugs we’ve had for a while. It works by hitting three different hormone targets in your body, which is a bit more than some other popular medications. But because it’s still being studied, you can’t just walk into a pharmacy and pick it up with a prescription. It’s not officially approved for general use. Timeline for Potential FDA Approval When might retatrutide get the green light from the FDA? The word on the street is that the final stages of testing, the big Phase 3 trials, are wrapping up. Based on how things are progressing, many are expecting the FDA to make a decision sometime in the summer of 2026. Of course, timelines like these can shift a bit. Drug approval is a thorough process, and the FDA needs to be sure about safety and effectiveness before giving it the go-ahead for everyone. So, while summer 2026 is the target, we’ll have to wait and see. Is Retatrutide FDA Approved Today? To be super clear: no, retatrutide is not FDA approved today. As of right now, the only way to legally access it is by participating in a clinical trial. You won’t find it prescribed by your doctor or sold by legitimate pharmacies. If you see it advertised for sale online or elsewhere, it’s important to be really cautious. It’s likely not the real deal, and definitely not safe or legal to use outside of a controlled study. Stick to official channels if you’re interested in trying it. How to Access Retatrutide Join 15,000+ Patients Check eligibility in under 10 minutes No insurance No fees All 50 states Begin Free Quiz → Affirm. Klarna. HSA/FSA. 0% APR Retatrutide Availability Through Clinical Trials Right now, if you’re looking to get your hands on retatrutide, your only legal and safe route is through a clinical trial. It’s not something your doctor can prescribe yet, and you won’t find it at your regular pharmacy or legitimate online stores. The drug is still in the testing phase, with Phase 3 trials wrapping up soon. Think of it like this: the researchers are still gathering all the final data they need to show the FDA that it’s safe and effective for everyone. So, any place claiming to sell it outside of these official studies is not on the up and up, and you should steer clear. Finding and Enrolling in Retatrutide Trials So, how do you actually find one of these trials? A good starting point is a website like ClinicalTrials.gov. It’s a big database that lists studies happening all over the world. You can search for "retatrutide" or terms like "triple-agonist obesity trial." When you find a trial that looks interesting, you’ll need to read the details very carefully. They’ll have specific requirements about who can join, like your health history, age, and other medical conditions. It’s also important to check the trial’s location and what the schedule looks like. Don’t just jump into signing up; make sure it fits with your life and your health needs. Risks and Considerations for Clinical Trial Participation Getting into a clinical trial isn’t just about finding the drug; there are things to think about. First off, you need to talk to your doctor. They can help you figure out if a trial is a good idea for you, especially if you have any existing health issues like stomach problems, gallbladder disease, or kidney or liver concerns. Retatrutide can affect how your body absorbs other medications, so you’ll want to go over everything you’re currently taking. Also, remember that trials are studies. While they aim to help, there’s always a chance of unexpected side effects or that the drug might not work as well for you as it does for others. It’s a commitment, and you need to be comfortable with the unknowns that come with being part of research. Retatrutide’s Mechanism of Action Medical Care from $99/Month Semaglutide and tirzepatide programs Triple free promise All 50 states Licensed doctors View All Programs → Affirm. Klarna. Afterpay. HSA/FSA accepted How Retatrutide Targets Multiple Receptors So, how does retatrutide actually work? It’s a bit different from some of the other weight loss medications you might have heard about. Instead of just hitting one target in your body, retatrutide is designed to interact with three different hormone receptors. Think of it like having a multi-tool instead of just a screwdriver. It targets the GLP-1 receptor, which is known to help manage appetite and blood sugar. Then it also hits the GIP receptor, which plays a role in how your body responds to insulin. And finally, it works on the glucagon receptor, which influences how your body uses energy and breaks down fat. By acting on all three of these pathways, retatrutide can influence appetite, slow down how quickly your stomach empties, and affect how your body uses and stores energy. This combined action is thought to be why it shows such significant effects on weight loss in studies. Comparison to Existing GLP-1 Medications When we look at medications like Ozempic or Wegovy, they primarily focus on the GLP-1 receptor. Mounjaro and Zepbound take it a step further by targeting both GLP-1 and GIP receptors. Retatrutide goes even further, as we just discussed, by adding the glucagon receptor into the mix. This triple-action approach is what researchers believe gives retatrutide its potential for greater weight loss compared to the dual-action drugs. Early results suggest that people taking retatrutide

Understanding Retatrutide’s Mechanism of Action LegitScript Talk to a Board-Certified Doctor Free consultation. 15,000+ patients. From $99/month ✓ Free visit ✓ Free shipping ✓ Free supplies Start Free Consultation → Affirm. Klarna. Afterpay. HSA/FSA How Retatrutide Targets Multiple Receptors So, how does this new drug, retatrutide, actually work to help people lose weight? It’s pretty interesting. Instead of just focusing on one thing in your body, retatrutide is designed to act on several different hormone receptors. Think of your body like a complex system with lots of different switches. Retatrutide is like a master key that can flip a few of these important switches all at once. This multi-target approach is what makes it stand out from some older medications. It’s not just a one-trick pony; it’s working on multiple fronts to influence how your body manages energy and stores fat. The Role of GLP-1, GIP, and Glucagon Pathways Specifically, retatrutide is a triple agonist. That means it activates three key hormone pathways that are involved in metabolism and appetite control. First, it mimics the action of GLP-1, a hormone that tells your brain you’re full and slows down how quickly food leaves your stomach. Then, it also acts on the GIP receptor, another hormone that plays a role in insulin release and fat storage. But here’s where it gets really unique: it also activates the glucagon receptor. Glucagon is often seen as the opposite of insulin, and by activating its receptor, retatrutide can help the body use stored energy and potentially burn more fat. This combination is a big deal because it addresses different aspects of how our bodies regulate weight. Impact on Appetite and Metabolism When retatrutide hits these receptors, it has a pretty direct effect on how you feel and how your body uses energy. By influencing GLP-1 and GIP, it helps you feel satisfied with less food, which naturally leads to eating fewer calories. It can also slow down digestion, making that feeling of fullness last longer. On the metabolism side, the glucagon pathway activation might encourage your body to tap into its fat reserves for energy. So, you’re not only eating less, but your body might also be more inclined to burn the fat it already has. This dual action—reducing food intake and influencing energy expenditure—is the core of how retatrutide helps drive changes in body weight. Clinical Trial Results for Retatrutide Weight Loss Join 15,000+ Patients Check eligibility in under 10 minutes No insurance No fees All 50 states Begin Free Quiz → Affirm. Klarna. HSA/FSA. 0% APR Significant Weight Reduction Observed So, what did the studies actually show when people took retatrutide? The results have been pretty striking, honestly. Participants in the trials saw a really substantial drop in their body weight. We’re talking about numbers that are quite a bit higher than what we’ve seen with some other medications out there. It wasn’t just a little bit of weight either; for many, it was a significant percentage of their total body weight lost over the course of the study. This level of reduction is what makes retatrutide stand out. Comparison with Existing Weight Loss Medications When you put retatrutide next to the weight loss drugs we’ve had for a while, it seems to perform better in terms of how much weight people lose. Think about the drugs that have been the go-to options; retatrutide appears to help people shed more pounds. This is a big deal because finding treatments that work really well for obesity has been a challenge. The data suggests retatrutide might be a more powerful tool in the toolbox for doctors and patients. Patient Demographics and Response Rates The studies included a range of people, different ages and backgrounds, which is good for seeing how it works across the board. What’s interesting is that the amount of weight lost wasn’t the same for everyone. Some people responded more strongly than others. This is pretty typical with medications, but it’s something researchers are looking at closely to figure out why some individuals see bigger changes. Understanding who benefits the most is key to using this drug effectively down the line. The Science Behind Retatrutide’s Efficacy Medical Care from $99/Month Semaglutide and tirzepatide programs Triple free promise All 50 states Licensed doctors View All Programs → Affirm. Klarna. Afterpay. HSA/FSA accepted Dual and Triple Agonism Explained So, what makes retatrutide stand out from the crowd? It’s all about how it works in your body. Unlike some other medications that focus on just one pathway, retatrutide is a bit of a multi-tasker. It’s designed to hit three different hormone receptors: GLP-1, GIP, and glucagon. Think of these hormones as messengers in your body that help control things like appetite, how your body uses energy, and even how much fat it stores. By acting on all three, retatrutide can have a more powerful effect on weight loss than drugs that only target one or two. This triple action is pretty new and seems to be a big reason why people are seeing such significant results. It’s like having a team of three working together to get the job done, rather than just one person. Effects on Body Composition When people lose weight, it’s not just about the number on the scale dropping. What’s really important is what kind of weight is being lost. We want to lose fat, not muscle, right? Early studies on retatrutide suggest that it’s pretty good at helping people shed fat. While some muscle loss can happen with any significant weight reduction, the data so far indicates that retatrutide might help preserve lean body mass better than some other methods. This is a big deal because muscle is important for keeping your metabolism humming and for overall strength. The goal is to become healthier, not weaker, and maintaining muscle is a key part of that. It seems like retatrutide is helping people achieve a better body composition, which is a more complete picture of health than just weight

Understanding The GLP-1 Revolution LegitScript Talk to a Board-Certified Doctor Free consultation. 15,000+ patients. From $99/month ✓ Free visit ✓ Free shipping ✓ Free supplies Start Free Consultation → Affirm. Klarna. Afterpay. HSA/FSA The Current Landscape of Obesity Treatment For a long time, treating obesity felt like a losing battle. Doctors often talked about willpower and lifestyle changes, and while those things are important, they didn’t always work for everyone. Obesity is a really complex health issue, and we didn’t have many tools that made a big difference. Then came the GLP-1 drugs. Suddenly, we had medications that could help people lose a significant amount of weight, which was a huge step forward. These drugs started changing how we think about obesity, moving the conversation away from just personal responsibility and towards understanding the biology behind it. It felt like a real turning point, offering hope where there was often frustration. Limitations of Existing GLP-1 Medications While the current GLP-1 medications have been amazing for many, they aren’t perfect. Most of them require weekly injections, which can be a hassle for some people. They can also be pretty expensive, making them hard to access for a lot of individuals. And let’s not forget the side effects – things like nausea and stomach upset are pretty common, and they can really impact daily life. Plus, there’s still a question mark about what happens when people stop taking them. Will the weight stay off? We’re still gathering data on that, and it’s something we need to keep an eye on as more people use these drugs long-term. The Science Behind GLP-1 Agonists So, what exactly are these GLP-1 drugs doing? They mimic a hormone your body naturally makes after you eat. This hormone, GLP-1, tells your brain you’re full, which helps you eat less. It also helps manage blood sugar and slows down how quickly your stomach empties. But the really interesting part is how much the brain is involved. It turns out that a lot of the appetite-suppressing effect happens right in our heads. Scientists have been studying how our bodies regulate hunger and energy for decades, and these drugs are a result of that hard work. They’re like supercharged versions of our natural hormones, and they’re showing us just how much our biology plays a role in weight. Retatrutide: A Triple Agonist Breakthrough Join 15,000+ Patients Check eligibility in under 10 minutes No insurance No fees All 50 states Begin Free Quiz → Affirm. Klarna. HSA/FSA. 0% APR How Retatrutide Targets Multiple Receptors So, what makes retatrutide stand out from the crowd? It’s a bit like having a multi-tool instead of just a screwdriver. While the GLP-1 drugs we’ve seen so far are pretty amazing, retatrutide goes a step further by hitting not one, not two, but three different hormone receptors. Think of it as a triple threat for metabolism. It targets GLP-1, which helps with appetite and insulin, but it also hits GIP, another hormone involved in blood sugar and fat storage, and glucagon, which plays a role in energy use and blood sugar. By activating all three, it’s like sending out a coordinated signal to different parts of your body that manage how you use energy and store fat. This multi-receptor approach is what researchers believe can lead to even bigger results. Potential for Greater Weight Loss Because retatrutide is working on multiple fronts, the early results are pretty eye-opening. We’re talking about changes in body weight, potentially more than what we’ve seen with the current top-tier medications. In some studies, people have lost over 20% of their body weight, which is a really substantial amount. It’s not just about shedding pounds, though; it’s about how the body responds to this multi-pronged attack on metabolic processes. The idea is that by influencing GLP-1, GIP, and glucagon all at once, the body becomes more efficient at using fat for energy and less likely to store it. This could be a game-changer for individuals who haven’t found success with other treatments. Synergistic Effects Beyond GLP-1 It’s not just about adding up the effects of each hormone it targets; it’s about them working together. When you activate multiple receptors that are located in different tissues, or even on the same cells, the effects can be much greater than just the sum of their parts. This is called synergy. For example, activating both GLP-1 and GIP receptors seems to have a bigger impact on appetite control and fat metabolism than activating just one. Adding glucagon into the mix might further boost how the body burns calories and manages fat in the liver. This combined action is what researchers are really excited about, as it suggests a more powerful and potentially more complete way to address the complex issue of weight management and metabolic health. What To Expect From Retatrutide in 2026 Medical Care from $99/Month Semaglutide and tirzepatide programs Triple free promise All 50 states Licensed doctors View All Programs → Affirm. Klarna. Afterpay. HSA/FSA accepted So, what’s the big deal with retatrutide and what can we realistically expect as we move into 2026? Well, the buzz is definitely around its potential for even more changes in body weight compared to the GLP-1 drugs we’ve seen so far. Think about it – retatrutide isn’t just a one-trick pony; it’s a triple agonist, meaning it hits three different hormone receptors: GLP-1, GIP, and glucagon. This multi-pronged attack seems to really rev up the body’s metabolism and appetite control in ways that single-receptor drugs just can’t match. Early studies have shown some pretty impressive numbers, with participants shedding a substantial amount of weight, sometimes over 20%. That’s a game-changer for many people struggling with obesity. Beyond just the number on the scale, we’re also looking at potential improvements in other metabolic markers. We’re talking about things like blood sugar control, cholesterol levels, and maybe even fatty liver disease. The idea is that by targeting multiple pathways, retatrutide could offer a more comprehensive approach

GLP-1 medications have generated extraordinary clinical and public interest — and for good reason. These are among the most effective pharmacological tools for metabolic health management ever developed. But media coverage, social media testimonials, and word-of-mouth accounts often diverge significantly from clinical reality. Understanding what GLP-1 programs actually deliver — and what they require from you — is the foundation of a successful treatment experience. The “Magic Pill” Misconception GLP-1 medications are not passive interventions. They address the hormonal drivers of appetite dysregulation and metabolic imbalance — but they do not override poor dietary choices, physical inactivity, or chronic stress. Patients who approach GLP-1 programs as standalone solutions consistently underperform compared to those who integrate the medication with meaningful lifestyle changes. The medication provides a hormonal foundation — reduced appetite, improved satiety signaling, better glycemic stability — that makes meaningful lifestyle change significantly easier than it is without medical support. But the work of building sustainable habits still falls to the patient. Those who achieve the most lasting results use the treatment window to develop dietary patterns and movement habits that can sustain their progress beyond the active treatment phase. Understanding GLP-1 Medication Options GLP-1 medications differ in their receptor targets, dosing schedules, and clinical efficacy profiles. Compounded semaglutide is a GLP-1 receptor agonist — it activates one hormonal receptor pathway. Compounded tirzepatide is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist — it activates two receptor pathways simultaneously, which accounts for the greater average weight reduction seen in the SURMOUNT-5 trial (NEJM, 2025). Both medications share a similar GI side effect profile and are administered as weekly subcutaneous injections. Your licensed CoraDoc provider determines which medication is appropriate based on your health history, metabolic profile, prior treatment experience, and goals. There is no universally superior option — there is the option most appropriate for your individual health profile. Honest Side Effect Expectations Gastrointestinal side effects — nausea, constipation, diarrhea, abdominal discomfort — are common during the initial weeks of GLP-1 treatment and during dose escalations. For most patients, they are also temporary. Understanding that these symptoms are expected and transient helps patients avoid premature discontinuation during the most critical phase of treatment. The weight loss plateau that many patients experience after several months is equally misunderstood. When body weight stabilizes, the medication has not stopped working — it is performing its other critical functions: maintaining blood sugar regulation, supporting satiety, and preserving the metabolic improvements achieved during the active weight loss phase. Discuss any concerns about your progress with your CoraDoc provider before making changes to your program. Individualizing Your Program Titration at Your Pace GLP-1 titration is not a race. Starting at a low dose and increasing gradually over several weeks is the clinical standard — and patients who follow their prescribed titration schedule experience meaningfully fewer GI side effects and better long-term adherence than those who self-advance prematurely. If you are experiencing significant discomfort at your current dose, discuss temporarily holding the dose increase with your CoraDoc provider until your body adapts more fully. This is a clinically sound approach, not a setback. Personalized Dietary Guidance GLP-1 medications reduce appetite — they do not guide food quality. What you eat within your reduced caloric intake matters significantly. Adequate lean protein (0.7–1.0 g per pound of body weight daily) preserves muscle mass during weight loss. Non-starchy vegetables provide essential fiber and micronutrients. Whole grains provide sustained energy. Generic dietary advice rarely translates to sustainable individual practice — work with your provider to develop an eating pattern that fits your schedule, food preferences, and metabolic needs. Lifestyle: The Multiplier That Determines Long-Term Outcomes Exercise and Muscle Preservation Physical activity is not optional in a well-designed GLP-1 program. Resistance training specifically is critical for preserving lean muscle mass during weight loss — without it, the body loses muscle alongside fat, which slows resting metabolic rate and makes long-term weight maintenance significantly harder. Even 2–3 resistance training sessions per week combined with daily moderate activity produces meaningful improvements in body composition and metabolic outcomes. Build intensity gradually, particularly during the GI adjustment period. Food Noise: An Underrecognized Benefit One of the most consistently reported transformative effects of GLP-1 therapy is the reduction of “food noise” — the persistent mental preoccupation with eating, cravings, and food that characterizes metabolic dysregulation. For many patients, this is the first meaningful relief from compulsive food-related thinking they have experienced. This window represents a meaningful opportunity to establish more intentional, nourishing eating patterns while appetite regulation support is strongest. Protein and Nutritional Status A significant risk in GLP-1 programs is under-consumption of protein and micronutrients as appetite decreases. Appetite suppression reduces quantity — but nutritional quality requires deliberate attention. Patients who do not proactively target adequate protein intake risk muscle loss during the weight loss phase, which reduces resting metabolic rate and complicates long-term maintenance. Your CoraDoc provider can establish minimum nutritional targets for your program during your free consultation. Long-Term Success: Building Beyond the Active Phase The most successful GLP-1 program patients are those who treat the medication as the beginning of a metabolic transformation — not the entire process. The medication provides the hormonal foundation. The lifestyle habits built during treatment determine whether results are sustained afterward. Obtaining GLP-1 medications from unregulated or non-clinical sources carries significant safety risks — counterfeit or incorrectly dosed medications are a documented problem in the marketplace. CoraDoc medications are dispensed through DIRX, a licensed U.S. pharmacy, under the supervision of board-certified physicians. All programs are LegitScript certified. If you are experiencing cost or access concerns, contact CoraDoc’s care team directly at 855-983-5336 for guidance on options available to you. Frequently Asked Questions What if I feel like the medication isn’t working? Contact your CoraDoc provider. Perceived ineffectiveness is often a dose issue — the therapeutic dose for meaningful appetite regulation may not have been reached yet if you are still in the titration phase. Your provider can assess your current dose, review adherence and lifestyle

Understanding Tirzepatide Storage Requirements LegitScript Talk to a Board-Certified Doctor Free consultation. 15,000+ patients. From $99/month ✓ Free visit ✓ Free shipping ✓ Free supplies Start Free Consultation → Affirm. Klarna. Afterpay. HSA/FSA When you get your Tirzepatide, whether it’s Mounjaro or Zepbound, the first thing to know is that it really likes the cold. Keeping it in the refrigerator is the best way to make sure it stays good until the date printed on the box. The ideal spot for it is between 36°F and 46°F. Think of it like keeping your milk fresh; the fridge is its happy place. This temperature range helps maintain its stability and effectiveness over time. It’s also a good idea to keep it in its original packaging. That box isn’t just for show; it helps protect the medication from light, which can also affect how well it works. Before you use any dose, take a quick look. The liquid should be clear, maybe a little bit yellow, but definitely not cloudy or with anything floating in it. If it looks off, don’t use it. Tirzepatide Stability Outside Refrigeration Join 15,000+ Patients Check eligibility in under 10 minutes No insurance No fees All 50 states Begin Free Quiz → Affirm. Klarna. HSA/FSA. 0% APR So, what happens if you can’t keep your Tirzepatide in the fridge all the time? It turns out, it’s not the end of the world, but you do need to be mindful. The medication can hang out at room temperature, as long as it stays below 86 degrees Fahrenheit. For a period of up to three weeks, it should be just fine. Think of it like this: if you’re going on a short trip and can’t bring a cooler, you’ve got a window of about 21 days to keep it with you. However, there’s a pretty important rule here – once it’s been out of the fridge, you can’t put it back in. So, if you take it out, you need to use it within that 21-day timeframe or toss it. Leaving it out for longer than that, or if the temperature creeps above that 86-degree mark, could mean the medicine just doesn’t work as well as it should. The active ingredients can start to break down, and you don’t want that. If you’re ever unsure if it got too warm or how long it’s been out, it’s always better to be safe than sorry and talk to your doctor or pharmacist. Handling Tirzepatide After Room Temperature Exposure Medical Care from $99/Month Semaglutide and tirzepatide programs Triple free promise All 50 states Licensed doctors View All Programs → Affirm. Klarna. Afterpay. HSA/FSA accepted So, what happens if your Tirzepatide pen or vial accidentally spends a bit too much time out of the fridge? It’s a common worry, and honestly, it’s good to be aware of the rules. The main thing to remember is that Tirzepatide can hang out at room temperature, as long as it’s not warmer than 86°F (that’s about 30°C), for a total of 21 days. If it’s been out for that long, or if you suspect it got too warm, you can’t just pop it back in the fridge and pretend it’s all good. Once it’s been exposed to room temperature for that 21-day window, you need to use it within that time or get rid of it. Putting it back in the fridge doesn’t reset the clock, and it might not be as effective if it’s been compromised. If you’re ever unsure about how long it’s been out or if it got too hot, it’s always best to play it safe. Don’t use it, and reach out to your doctor or pharmacist to figure out the next steps. They can help you get a replacement if needed. Also, keep an eye out for any changes in how the medication looks – if it’s cloudy or discolored, that’s another sign to avoid using it, even if it hasn’t technically expired. Travel Considerations for Tirzepatide LegitScript Get Started in 3 Simple Steps Intake. Doctor consult. Free delivery. 1 10-min intake 2 Free video visit 3 Free delivery Start Free Consultation → Join 15,000+ patients. Affirm. Klarna. HSA/FSA When you’re planning a trip, especially one that involves flying, thinking about how to pack your Tirzepatide is pretty important. You definitely want to keep it safe and effective, right? So, keeping your medication with you in your carry-on bag is the way to go. Checked luggage can get lost, or worse, end up in places where the temperature can get really extreme, either too hot or too cold. Since Tirzepatide can handle being out of the fridge for up to three weeks, as long as it stays below 86°F, it’s usually fine for most trips. Just make sure it’s not sitting in a hot car or out in direct sunlight for too long, because that heat can mess with the medicine. If you’re traveling internationally, it’s a good idea to check the rules for the countries you’re visiting regarding bringing in medications, especially injectables. Sometimes, having a note from your doctor can be helpful, and keeping the medication in its original packaging with the pharmacy label is always a smart move. It just makes things smoother if you have to go through security or customs. The Significance of Expiration Dates Start Free Quiz. $99/Month Free visit. Free shipping. 15,000+ patients trusted Get Started Risk-Free → Affirm. Klarna. Afterpay. HSA/FSA. LegitScript Everything has a shelf life, and that includes your tirzepatide injections. You’ll see an expiration date printed on the packaging, and that’s not just a suggestion. It’s basically the manufacturer’s promise that the medicine will work as intended and stay stable, but only if you’ve kept it stored properly. Think cool temperatures, away from light, and never frozen, all while it’s in its original box. Once that date passes, the game changes. Manufacturer’s Guarantee and Storage Conditions The expiration date is tied directly to how the medication is stored.

LegitScript Certified · All 50 States · From $99/Month GLP-1 Program Comparison 2026: Costs, Benefits & What Actually Matters Choosing the right GLP-1 program is about more than price. Here is what to compare and why CoraDoc’s one-time payment model changes the math. See CoraDoc Pricing The GLP-1 Cost Landscape in 2026 GLP-1 medications have transformed metabolic health treatment. The STEP 1 trial (NEJM 2021) and SURMOUNT-5 trial (NEJM 2025) established clinically meaningful outcomes. But for most patients paying out of pocket, access has remained a cost barrier. Brand-name GLP-1 medications often cost $800–$1,200/month without insurance. Compounded GLP-1 options from telehealth platforms range from $75 to $399+/month — with significant variation in what’s actually included in that price. The 5 Most Important Things to Compare 1. All-In Cost vs. Advertised Price Platforms often advertise low medication prices but charge separately for consultation, shipping, and supplies. CoraDoc’s pricing is all-inclusive: $99/month for the 6-month semaglutide program includes the provider visit, medication, free 2-day shipping via DIRX pharmacy, and all supplies. No add-ons. 2. Subscription vs. One-Time Payment Monthly subscription billing creates a recurring financial decision point that causes early discontinuation. CoraDoc charges once per program — no auto-renew, no ongoing billing relationship. If you want to continue, that’s a new decision and new purchase. 3. LegitScript Certification LegitScript certification requires independent verification of prescribing practices, pharmacy standards, and legal compliance. Most GLP-1 telehealth platforms do not hold it. CoraDoc does. In 2026, multiple platforms received FDA warning letters for non-compliant practices. LegitScript-certified providers are held to ongoing verified compliance standards. 4. Real Physician Oversight GLP-1 prescriptions require genuine individual physician review — not algorithmic auto-approval. Every CoraDoc patient intake is reviewed by a board-certified physician before any prescription is issued. Your provider remains accessible throughout your program. 5. Pharmacy Sourcing Compounded GLP-1 medications should come from a licensed U.S. 503A compounding pharmacy under FDA oversight. CoraDoc’s pharmacy partner is DIRX, a licensed U.S. compounding pharmacy. Avoid providers who are vague about sourcing. 2026 GLP-1 Provider Comparison Provider Sema Rate Billing Shipping LegitScript CoraDoc $99/mo One-time Free 2-day Yes Hims & Hers ~$199/mo Subscription Included — Ro Health ~$199–349/mo Membership Varies — Noom Med ~$149–199/mo App subscription Varies — TrimRx ~$199/mo Subscription Varies — Why Program Length Affects Outcomes GLP-1 medications work through dose escalation over months. Clinical trials ran 68 weeks or longer. One-time payment programs remove the monthly billing friction that causes patients to discontinue subscription plans mid-treatment, before reaching a therapeutic dose or completing the full course. Exercise and Lifestyle Still Matter GLP-1 medications create favorable conditions for dietary change — but physical activity helps preserve lean muscle mass during weight loss and improves long-term outcomes. Your CoraDoc provider is available throughout your program to answer questions at 855-983-5336 or careteam@coradoc.com. LegitScript Certified · All 50 States · No Subscription Provider-Supervised GLP-1 Programs You Can Afford Semaglutide from $99/mo · Tirzepatide from $149/mo · Free visit · Free shipping · Free supplies · One payment. Begin Your Free Consultation Questions? Call 855-983-5336 or email careteam@coradoc.com Medical Disclaimer CoraDoc provides access to compounded semaglutide and compounded tirzepatide prescribed by licensed physicians. Compounded medications are not FDA-approved as finished drug products. Eligibility is determined solely by a licensed provider. Individual results vary. This content is informational only and not medical advice. CoraDoc is LegitScript certified. Call 855-983-5336 or email careteam@coradoc.com.

LegitScript Certified · HSA/FSA Accepted · All 50 States Can You Use HSA or FSA for Compounded Semaglutide? Complete 2026 Guide Understanding HSA and FSA eligibility for GLP-1 programs — including how CoraDoc’s one-time payment model simplifies the process. Start Your Free Consultation → Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are pre-tax benefit accounts that can significantly reduce the out-of-pocket cost of prescription medications. For patients using compounded semaglutide or tirzepatide through a licensed telehealth provider, these accounts can be a meaningful tool for making treatment more affordable. CoraDoc™ accepts both HSA and FSA cards directly. HSA vs. FSA: Key Differences Feature HSA (Health Savings Account) FSA (Flexible Spending Account) Eligibility Requires enrollment in a high-deductible health plan (HDHP) Offered by employers as a benefit; no HDHP required Rollover Funds roll over year to year indefinitely Use-it-or-lose-it — funds typically expire at year end (some plans allow limited rollover or grace period) Portability Yours to keep if you change jobs Generally tied to employer plan 2024 Contribution Limits $4,150 individual / $8,300 family $3,200 (employer may set lower limit) Interest/Growth Can earn interest; some plans allow investment No interest growth Is Compounded Semaglutide an Eligible HSA/FSA Expense? The IRS defines eligible medical expenses as those paid for the “diagnosis, cure, mitigation, treatment, or prevention of disease.” Prescription medications issued by a licensed physician for a diagnosed medical condition generally qualify under this definition. Compounded semaglutide and compounded tirzepatide, when prescribed by a licensed physician following individual medical review, are prescription medications. In most cases, they qualify as eligible expenses for both HSA and FSA accounts — provided the prescription is documented and the treatment is for a legitimate medical purpose. Important note: The IRS distinguishes between prescription medications (eligible) and purely cosmetic treatments (ineligible). If the prescription is for a weight-related medical condition — such as obesity, Type 2 diabetes, hypertension, or metabolic syndrome — the eligibility determination is generally straightforward. Always confirm with your specific HSA/FSA administrator, as plan-level rules may vary. Key Factors That Affect Eligibility Determinations Medical Necessity Documentation Your HSA/FSA administrator may request documentation that the medication was prescribed for a medical purpose. This typically means: A valid prescription from a licensed physician Documentation of the diagnosed condition being treated (provided through the physician’s records) In some cases, a Letter of Medical Necessity (LMN) — a formal note from your physician explaining the medical reason for the prescription CoraDoc™’s physician review process generates the documentation required to support HSA/FSA reimbursement claims. Your care team can assist with any documentation requests at careteam@coradoc.com. Plan-Specific Rules While the IRS establishes the general framework for eligible expenses, individual HSA and FSA plans can impose additional requirements. Some plans may: Require prior documentation for weight management medications specifically Have preferences for specific drug formulations (though compounded prescriptions from licensed pharmacies are generally eligible) Have varying reimbursement processes (direct card payment vs. submit-and-reimburse) Always contact your specific plan administrator to confirm requirements before making a payment, especially for medications in the weight management category. How CoraDoc™’s One-Time Payment Model Works with HSA/FSA CoraDoc™ accepts HSA and FSA debit cards directly at the time of purchase. Because CoraDoc operates on a one-time payment model — not a subscription — your HSA or FSA is charged once per program. There is no recurring monthly billing to manage or cancel. This has a practical advantage for FSA users: FSA accounts often require funds to be spent by December 31. A one-time program purchase is straightforward to plan for — you know the exact amount at purchase and can time it to your FSA benefit period. CoraDoc™ programs and their all-in pricing: Program Total Price Monthly Rate Semaglutide 6-Month Full Program $595 $99/mo Semaglutide 3-Month Standard $495 ~$165/mo Tirzepatide 6-Month Full Program $894 $149/mo Tirzepatide 3-Month Standard $695 ~$232/mo All plans include free provider visit, free 2-day shipping via DIRX pharmacy, and free supplies. One payment — no billing surprises, no recurring charges. How to Get a Letter of Medical Necessity If your HSA/FSA administrator requires a Letter of Medical Necessity (LMN) for reimbursement: Contact your CoraDoc™ care team at careteam@coradoc.com and request documentation support Your prescribing physician can provide a letter detailing the medical condition being treated and the clinical rationale for the prescription Submit the LMN along with your purchase receipt to your HSA/FSA administrator per their reimbursement process Keep copies of all documentation — prescriptions, purchase receipts, and LMN — for your records. Maximizing Your HSA/FSA for GLP-1 Programs Contribute the maximum allowed — especially if you are planning a 6-month program. For 2024: $4,150 individual HSA; $3,200 FSA. Time your purchase to your FSA year — FSA funds typically expire December 31. Purchasing your program before year-end uses funds you’ve already committed Use the HSA debit card directly — most CoraDoc purchases can be made directly with your HSA card, avoiding the submit-and-reimburse process Keep your prescription documentation — if your administrator requests verification, having your documentation ready speeds up the process Frequently Asked Questions Does CoraDoc accept HSA/FSA cards? Yes. CoraDoc™ accepts HSA and FSA debit cards as direct payment for GLP-1 programs. The charge is a one-time purchase — no recurring billing. Do I need a prescription for the purchase to qualify? Yes. A valid prescription from a licensed physician is required for HSA/FSA eligibility for prescription medications. Your CoraDoc™ physician review generates this prescription as part of the standard program process. What if my FSA administrator questions the eligibility? Contact careteam@coradoc.com. CoraDoc™ can assist with documentation needed for HSA/FSA reimbursement claims, including supporting your request for a Letter of Medical Necessity from your prescribing physician. Can I use my FSA for tirzepatide too? Yes. Compounded tirzepatide prescribed by a licensed physician for a qualifying medical condition is generally eligible as an FSA/HSA expense, subject to the same plan-specific rules that apply to semaglutide. Confirm with your plan administrator. HSA/FSA Accepted · LegitScript Certified · No Subscription Use Your HSA/FSA for a Provider-Supervised GLP-1 Program

Starting a provider-supervised GLP-1 program is one of the most meaningful steps you can take for your metabolic health — but like any effective medical treatment, GLP-1 receptor agonists involve a transition period. Understanding what to expect, why side effects occur, and how to manage them effectively is the difference between patients who push through and those who stop prematurely. This guide covers every major side effect category with doctor-approved strategies used by CoraDoc’s licensed providers. Managing Nausea on GLP-1 Medications Nausea is the most commonly reported side effect when starting a GLP-1 program. It occurs because GLP-1 medications slow gastric emptying — the rate at which your stomach releases food into the small intestine. While this mechanism is what produces the appetite-suppressing effects that make GLP-1s effective, it also means your digestive system is working differently than it did before. For most patients, nausea improves meaningfully within 4–8 weeks as the body adapts. Start Low and Titrate Slowly Your licensed provider will prescribe a starting dose well below your therapeutic target and increase it incrementally over several weeks. This graduated titration schedule is the primary clinical tool for minimizing nausea. Advancing the dose too quickly is the most common reason patients experience severe GI symptoms. Follow your prescribed schedule exactly and do not self-advance. Adjust Your Dietary Choices During the adjustment period, avoid high-fat meals, fried foods, heavily spiced dishes, and foods or drinks with artificial sweeteners — all of which stimulate gastric secretions and can amplify nausea. Lean proteins, steamed vegetables, whole grains, and simple broths are your best allies. Eating slowly and chewing thoroughly reduces digestive burden significantly. Eat Smaller, More Frequent Meals Shift from three large meals to four or five smaller ones throughout the day. This keeps your stomach partially full without overwhelming it and helps stabilize blood sugar between doses. Avoid lying down immediately after eating — remaining upright for at least 30 minutes post-meal reduces reflux and nausea. Ginger and Peppermint Both have well-established evidence for nausea relief. Ginger tea, ginger chews, or ginger capsules can calm an upset stomach. Peppermint tea is another option many patients find soothing. Always confirm with your provider before adding any supplement, particularly if you are taking other medications. Addressing Gastrointestinal Side Effects Beyond Nausea Preventing Constipation GLP-1 medications slow intestinal motility, making constipation common — especially in the first several weeks. The most effective prevention combines consistent hydration with adequate dietary fiber. Aim for 25–35 grams of fiber daily from whole food sources: vegetables, legumes, whole grains, and fruit. If dietary fiber alone is insufficient, discuss a fiber supplement with your provider. Daily light physical activity — even a 20-minute post-meal walk — meaningfully promotes intestinal motility and bowel regularity. Managing Diarrhea Some patients experience loose stools, particularly during dose escalation. This typically resolves within 1–2 weeks as your body adjusts. Maintain electrolyte intake with water and clear broths. Avoid sorbitol-containing foods and drinks such as diet sodas and sugar-free gum — sorbitol is an osmotic laxative that will worsen symptoms. If diarrhea persists beyond 2 weeks or is accompanied by fever or blood, contact your provider promptly. Vomiting and Stomach Upset If vomiting occurs, focus on clear fluids and ice chips until symptoms subside. Do not attempt a full meal while actively nauseous. If you cannot keep fluids down for more than 24 hours, contact your provider — dehydration can develop quickly and may require medical intervention. Your provider may temporarily hold a dose increase until symptoms stabilize. Managing Fatigue During GLP-1 Treatment Fatigue in the early weeks is often related to reduced caloric intake, blood sugar adjustments, and the metabolic changes the medication produces. It is typically temporary and resolves as your body adapts to treatment. Prioritize Sleep Quality Seven to nine hours of quality sleep per night is essential during active treatment. Maintain a consistent sleep schedule, limit screen exposure before bed, and avoid caffeine after 2 PM. Poor sleep elevates cortisol and ghrelin — hormones that increase appetite and can reduce the medication’s effectiveness. Ensure Adequate Protein Intake Fatigue during GLP-1 treatment is frequently linked to insufficient protein intake. As appetite decreases, patients may inadvertently under-consume protein, leading to energy dips and muscle fatigue. Target 0.7–1.0 grams of protein per pound of body weight daily. Lean meats, eggs, Greek yogurt, and protein shakes are practical high-protein options that support energy and muscle preservation throughout treatment. Light Physical Activity Moderate activity — a daily 20–30 minute walk — can reduce fatigue by improving circulation and neurochemical balance. Reserve higher-intensity exercise for periods when your energy has stabilized. Overexertion during the early adjustment weeks can worsen both GI symptoms and fatigue. Handling Injection Site Reactions Mild redness, swelling, or tenderness at the injection site is normal and typically resolves within 24–48 hours. Injection site reactions that persist beyond 72 hours, or that involve significant swelling, warmth, or discharge, should be reported to your provider. Proper Injection Technique Clean the injection site with an alcohol swab and allow it to dry fully before injecting. Insert the needle at the specified angle and inject steadily. Apply gentle pressure with a clean gauze pad after removing the needle — do not rub vigorously, as this increases bruising and local irritation. Rotate Injection Sites Inject in a different anatomical location each week, rotating between the abdomen, outer thigh, and upper arm as approved by your provider. Repeated injection into the same area causes tissue thickening (lipodystrophy) that can impair medication absorption. Keep a simple rotation log to track your sites if needed. Maintaining Blood Sugar Stability GLP-1 medications improve blood sugar regulation, but the transition period requires attention — particularly for patients also taking insulin or sulfonylureas, which can cause hypoglycemia when combined with GLP-1 therapy. Eat consistent, balanced meals at regular intervals and do not skip meals. Keep fast-acting glucose such as glucose tablets or juice accessible as a precaution. Your provider will monitor labs and adjust any co-prescribed diabetes medications as your GLP-1 dose increases

Understanding Semaglutide and Tirzepatide LegitScript Talk to a Board-Certified Doctor Free consultation. 15,000+ patients. From $99/month ✓ Free visit ✓ Free shipping ✓ Free supplies Start Free Consultation → Affirm. Klarna. Afterpay. HSA/FSA What is Semaglutide? Semaglutide is a medication that’s been around for a bit now, and many people know it as a way to help manage type 2 diabetes and also for weight loss. It works by mimicking a hormone your body naturally makes called GLP-1. This hormone does a few things, like telling your brain you’re full, which can help you eat less. It also slows down how fast your stomach empties, so you feel satisfied for longer. For people with type 2 diabetes, it helps lower blood sugar levels. You usually take it as a shot, though there’s also an oral version available. Doctors typically start you on a low dose and slowly increase it to help your body get used to it and reduce side effects like feeling sick to your stomach. What is Tirzepatide? Tirzepatide is a newer player in this field. It’s a bit different because it actually mimics two hormones: GLP-1, just like semaglutide, but also another one called GIP. This dual action is thought to be why it can be quite effective. Like semaglutide, it helps with blood sugar control in type 2 diabetes and is also used for weight management. It’s also given as an injection, and the dosing strategy is similar – starting low and going slow to manage any potential side effects. Some studies have shown that tirzepatide might lead to more weight loss compared to some other medications in its class, which is a big reason why people are interested in it. It’s important to discuss your specific health needs with your doctor to see if tirzepatide is right for you. Key Differences in Mechanism So, what really sets these two apart? The main difference is how they work in your body. Semaglutide is a GLP-1 receptor agonist, meaning it primarily targets the GLP-1 hormone pathway. Tirzepatide, on the other hand, is a dual agonist, hitting both the GLP-1 and GIP pathways. GIP (glucose-dependent insulinotropic polypeptide) is another hormone that plays a role in regulating blood sugar and appetite. By activating both pathways, tirzepatide might offer a broader effect on metabolism and weight loss for some individuals. Think of it like semaglutide being a very effective tool for one job, while tirzepatide is like a multi-tool that can handle a couple of related jobs at once. This difference in mechanism is a key reason why some people might experience different results or side effects with each medication. Reasons to Consider Switching Medications Join 15,000+ Patients Check eligibility in under 10 minutes No insurance No fees All 50 states Begin Free Quiz → Affirm. Klarna. HSA/FSA. 0% APR So, you’re thinking about making a switch from semaglutide to tirzepatide? That’s a pretty common thought these days, especially if you’re looking for a bit more oomph in your weight loss or blood sugar management. Both drugs are pretty impressive, but tirzepatide has a couple of tricks up its sleeve that might make it a better fit for some people. Enhanced Weight Loss Potential Let’s talk about weight loss first, because that’s a big one for a lot of us. While semaglutide is known for helping people shed pounds, studies have shown that tirzepatide often leads to even more changes in body weight. It’s not just a little bit more, either; the difference can be quite noticeable. This makes it a really attractive option if weight management is your primary goal, or if you’ve hit a plateau with your current medication. It seems to work a bit more powerfully on appetite control and how your body uses energy, which can make a real difference. Improved Glycemic Control For those managing type 2 diabetes, keeping blood sugar levels in check is obviously super important. Tirzepatide has demonstrated a strong ability to lower A1C levels, often more effectively than semaglutide. This means it can be a really good choice if your diabetes isn’t quite as controlled as you’d like it to be on semaglutide. Getting your blood sugar numbers down is key to avoiding those long-term diabetes complications, and tirzepatide seems to have an edge here. It’s good to know there are options that might work even better for your specific health needs. You can check out more information on diabetes management to get a better sense of the landscape. Broader Metabolic Benefits Beyond just weight and blood sugar, tirzepatide also offers what’s called broader metabolic benefits. This means it might have a positive impact on other aspects of your metabolism too. Think about things like how your body processes fats and sugars overall. Because tirzepatide works on two different hormone pathways (GLP-1 and GIP), it can influence your body in more ways than semaglutide, which primarily targets just one. This dual action is what gives it that extra metabolic boost, potentially leading to better overall health outcomes. It’s like getting a more comprehensive approach to managing your body’s systems. Factors Before Switching From Semaglutide to Tirzepatide Medical Care from $99/Month Semaglutide and tirzepatide programs Triple free promise All 50 states Licensed doctors View All Programs → Affirm. Klarna. Afterpay. HSA/FSA accepted Before you even think about switching from semaglutide to tirzepatide, it’s really important to have a good think about a few things. It’s not just a simple swap; you need to make sure it’s the right move for you and your health. First off, how well is semaglutide actually working for you right now? Are you hitting your weight loss goals or seeing the blood sugar improvements you hoped for? If things are going great, maybe sticking with it is the best plan. But if you feel like you’ve hit a plateau or aren’t getting the results you want, then exploring tirzepatide makes more sense. It’s always good to check in with your doctor about this, of course. They

Honest Comparison · Updated April 2026 Hims & Hers vs. CoraDoc: GLP-1 Program Comparison 2026 Both platforms offer compounded semaglutide. Here is exactly how they differ on price, billing model, certification, and what’s included. See CoraDoc’s All-In Pricing → Both Hims & Hers and CoraDoc™ offer telehealth access to compounded semaglutide for weight management. Both operate nationally. Both include physician oversight and pharmacy delivery. The differences — and there are significant ones — come down to price, billing model, compliance certification, and what’s included in the advertised monthly cost. This is a straightforward, factual comparison based on publicly available information as of April 2026. Side-by-Side Comparison Feature CoraDoc™ Hims & Hers Semaglutide Monthly Rate From $99/mo ~$199/mo Tirzepatide Monthly Rate From $149/mo ~$299–399/mo Billing Model One-time payment Monthly subscription Provider Visit Free — included Bundled in subscription Shipping Free 2-day — included Included in subscription Supplies Free — included Bundled LegitScript Certified Yes ✓ — All 50 States Yes Most states HSA/FSA Accepted Yes Yes BNPL (Affirm/Klarna) Yes Limited Pricing: $99/Month vs. ~$199/Month CoraDoc™’s 6-month semaglutide program costs $595 total — an effective monthly rate of $99. Hims & Hers charges approximately $199/month on a recurring subscription. Over a 6-month treatment period, that’s $595 with CoraDoc vs. approximately $1,194 with Hims — a $599 difference for comparable compounded semaglutide programs. For tirzepatide, CoraDoc charges $149/month (6-month program, $894 total). Hims & Hers tirzepatide ranges from approximately $299–$399/month on subscription. The savings difference over a 6-month course is material, particularly for cash-pay patients without insurance coverage for GLP-1 medications. Billing: One-Time Payment vs. Monthly Subscription This is a structural difference, not just a pricing difference. Hims & Hers operates on a monthly subscription model — your card is automatically charged each month until you actively cancel. CoraDoc™ uses a one-time payment model — you pay for your selected program once, no recurring billing is set up. Why this matters practically: Subscription billing requires active cancellation to stop — easy to forget during a busy month Month-to-month billing creates a recurring financial decision point that can cause treatment discontinuation before completing a full program One-time payment removes billing friction — you decide to continue only when you’re ready to reorder LegitScript Certification: CoraDoc Has It, Hims Does Not LegitScript certification is the independent verification standard for online healthcare providers used by Google and Meta to determine whether platforms can advertise GLP-1 medications by name. Certification requires passing a rigorous review of prescribing practices, pharmacy sourcing, physician oversight protocols, and legal compliance. CoraDoc™ is LegitScript certified. Hims & Hers is not listed as LegitScript certified for its GLP-1 programs as of 2026. In 2026, the FDA issued warning letters to multiple GLP-1 telehealth platforms for non-compliant practices. LegitScript certification distinguishes providers operating under ongoing verified compliance standards. What’s Included: Triple Free Promise vs. Bundled Subscription CoraDoc™ explicitly breaks out what’s included in every program: Free provider visit — $0 physician consultation, individually reviewed by a board-certified doctor Free 2-day shipping — via DIRX, a licensed U.S. 503A compounding pharmacy Free supplies — syringes, alcohol swabs, sharps container Hims & Hers bundles consultation, medication, and shipping into its monthly subscription. The program also includes access to nutrition content and a companion app. For patients who want app-based behavioral coaching alongside medication, Hims offers that layer. For patients focused primarily on medication access at a lower total cost with a one-time payment, CoraDoc’s model is more economical. Physician Oversight Both platforms require a physician review before any GLP-1 prescription is issued. CoraDoc™’s physician group (DoctorsNow) reviews each patient intake individually — no algorithmic auto-approval. Your provider remains available throughout your program at careteam@coradoc.com or 855-983-5336, Monday–Friday, 9am–7pm CST. Hims & Hers also involves licensed physician review as part of its sign-up process. Both platforms use asynchronous intake evaluation for initial prescription approval. Which Is Better for Your Situation? Choose CoraDoc™ if you: Want the lowest all-in monthly cost for compounded semaglutide or tirzepatide Prefer not to commit to a recurring monthly subscription Want to work with a LegitScript-certified provider Want to pay with HSA/FSA, Affirm, Klarna, or Afterpay in a one-time purchase Consider Hims & Hers if you: Want an integrated app with nutrition tracking, recipes, and lifestyle coaching built into the platform Are comfortable with monthly subscription billing Are willing to pay ~$199/month vs. $99/month for the broader platform features Frequently Asked Questions Is CoraDoc™ or Hims & Hers more affordable? CoraDoc™ is significantly more affordable on a per-month basis. Semaglutide at $99/month (CoraDoc 6-month program) vs. approximately $199/month (Hims) — a 50% cost difference over a comparable treatment period. Does CoraDoc have a free doctor visit? Yes. The physician consultation is included at no additional charge in every CoraDoc™ program. There is no separate consultation fee at any stage. Is Hims & Hers LegitScript certified? Hims & Hers is not listed as LegitScript certified for its GLP-1 programs as of April 2026. CoraDoc™ holds LegitScript certification. LegitScript Certified · All 50 States · No Subscription CoraDoc™: Half the Price, LegitScript Certified Semaglutide from $99/mo · Tirzepatide from $149/mo · Free visit · Free shipping · Free supplies · One payment. Begin Your Free Consultation → Questions? Call 855-983-5336 or email careteam@coradoc.com Medical Disclaimer CoraDoc™ provides access to compounded semaglutide and compounded tirzepatide prescribed by licensed physicians following individual medical review. Compounded medications are not FDA-approved as finished drug products. Eligibility is determined solely by a licensed provider based on your individual health profile. Individual results vary — outcomes depend on dosage, adherence, diet, physical activity, and individual health factors. This content is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any prescription program. CoraDoc™ is LegitScript certified. Call 855-983-5336 or email careteam@coradoc.com.